Marc Wilson, CFO at Crinetics Pharmaceuticals, Inc. (CRNX), sold 25,000 shares at $55.00 ($1.4M) on 2024-07-15, disclosed to the SEC on 2024-07-17.
Scheduled sale ($1.4M) by CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CRNX | SELL | 2024-07-02 | $2.8M | — | Filing → |
| CRNX | SELL | 2024-03-20 | $596K | — | Filing → |
| CRNX | SELL | 2024-01-04 | $355K | — | Filing → |